CRAASH Barcelona | Regulatory Aspects for Medical Devices

Dominique Monferrer, Medical Device Director at Asphalion, has been invited to give a talk on Regulatory Aspects for Medical Devices to participants of this year´s edition of Craash Barcelona, a program organized by Biocat in collaboration with CIMIT and EIT Health.

Dominique Monferrer, Medical Device Director at Asphalion, has been invited to give a talk on Regulatory Aspects for Medical Devices to participants of this year´s edition of Craash Barcelona, a program organized by Biocat in collaboration with CIMIT and EIT Health.
October 18, 2021

Dominique Monferrer, Medical Device Director at Asphalion, has been invited to give a talk on Regulatory Aspects for Medical Devices to participants of this year´s edition of Craash Barcelona, a program organized by Biocat in collaboration with CIMIT and EIT Health.

CRAASH Barcelona is a 3-month program that helps Catalan-based research teams and startups launch successful device, diagnostic and digital health innovations to improve health and patient care. It is one of the flagship programs of Moebio, Biocat´s initiative that brings together diferent training programs to accelerate entrepreneurship and innovation in healthcare.

Through CRAASH Barcelona, teams will have the opportunity to:

  • Validate their market and business model
  • Pitch to a panel of investors
  • Get more than 35 hours of mentoring from experienced US and EU experts
  • Access to a wide community of founders, KOLs, mentors, industry veterans and stakeholders.

For further information: https://www.moebio.org/en/program/craash-barcelona

Search News & Events

  • Filter by category

Share

Related news and events

NEWS | High-risk medical devices pilot

EMA has launched a pilot to give scientific advice on the intended clinical development strategy and proposals for clinical investigation for certain high-risk medical devices.

NEWS | New Insight on the Implementation of MDR Article 17

Article 17 of Regulation (EU) 2017/745 (Medical Device Regulation – MDR) regulates the reprocessing of single-use devices (SUDs) with relevance for the European Economic Area (EEA) which may only take place where permitted by national law and in accordance with this article.

The European Union’s AI Act & its Impact on Medical Devices

The AI Act (AIA) is the EU’s first attempt to create a comprehensive AI regulatory framework and aims to ensure the protection of fundamental rights in this field. AI applications used in healthcare are often ‘medical devices’ and are thus regulated under the EU Medical Devices Regulation (MDR).

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting